Glenn Baity, VP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 20,602 shares at $5.25 ($125K) on 2012-11-28, disclosed to the SEC on 2012-11-29.
Scheduled sale ($125k) by VP AND GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.28 | 16,206 | $102K | 81.5% |
| 2 | $5.25 | 4,396 | $23K | 18.5% |
| Total | $6.06 avg | 20,602 | $125K | 100% |
| Filing → |
| ACAD | SELL | 2017-10-06 | $3.1M | — | Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |